期刊文献+

阿托伐他汀对高血压病血vWF及BNP影响的近期疗效观察 被引量:2

Effects of atorvastatin on serum vWF and BNP in patient with hypertension
下载PDF
导出
摘要 目的探讨不同剂量阿托伐他汀治疗对血管内皮功能及脑钠肽(BNP)水平的影响。方法在我院确诊的150例高血压病同时具有高脂血症患者随机分成A、B、C三组,分别接受10、20、40 mg/d阿托伐他汀治疗4周。比较3组血脂水平、血管内皮功能相关指标血管性假性血友病因子(vWF)及BNP水平。结果与治疗前比较,不同剂量阿托伐他汀治疗组vWF及BNP水平均明显下降,C组明显低于A、B组(P<0.01),3组不良反应相似。结论阿托伐他汀降脂治疗可改善高血压病患者的内皮功能,40 mg阿托伐他汀作用比较明显。 Objective To assess effects of atorvastatin on serum vWF and BNP in patient with hypertension. Methods 150 patients with hypertension combined with hyperlipoidemia were divided into group A, B and C randomly. They were treated by atorvastatin with the concentration of 10, 20, 40 mg/d respectively. The total period of treatment was 4 weeks. TC, TG, LDL-C, HDL-C, vWF, BNP were measured in disorder lipoidemic group of pretreatment and treatment after 4 weeks. Results The level of vWF and BNP after treatment were decreased significantly in all patients. The level of vWF and BNP in 40 mg/d group were lower than those in 10 group and 20 mg/d group. Conclusion Atorvanstain may significandy reduce lipid and improve endothelial function in hyperlipoidemic patients. 40mg/d atorvastatin has better effect.
出处 《山东医药》 CAS 北大核心 2008年第1期13-15,共3页 Shandong Medical Journal
基金 河北省卫生厅科研立项课题(07430)
关键词 高血压病 阿托伐他汀 von WILLEBRAND因子 脑钠肽 hypertension disease atorvastatin yon Willebrand factor B-type natriurefic peptide
  • 相关文献

参考文献5

  • 1林金秀,彭峰,柴大军.阿托伐他汀钙对高血压病患者餐后甘油三酯代谢异常及血管内皮功能的影响[J].高血压杂志,2005,13(4):209-213. 被引量:13
  • 2Vita JA, Gokce N, Duffy SJ, et al. Effect of atorvastatin onendothelium-dependent vasodilation in patients with coronaryartery disease [J]. Am J Cardiol, 2003,91 (6) :857-860.
  • 3Ferrier KE, Muklmann MH, Baguet JP, et al. Intensive cho-lesterol reduction lowers blood pressure and large artery stiff-ness in isolated systolic hypertension [ J ]. J Am Coll Cardiol, 2002,39 ( 3 ) : 1020- 1025.
  • 4Tsiara S, Elisaf M, Mikhailidis DP. Early vascular benefits ofstatin therapy [J]. Curr Med Res Opin, 2003,19(8) :540-556.
  • 5Vitovec B, Delgado R, Zewail A, et al. Prolonged QTc interval andhigh B- type natriuetic peptide levels together predict mortality inpatients with advanced heart failure [J]. Circulation, 2003,107 ( 11 ) : 1764 -1769.

二级参考文献14

  • 1Atherosclerosis research unit effect of atorvastatin on postprandial plasma lipoproteins in postinfaction patients with combined hyperlipidemia[J].Atherosclerosis,2002,162:163-170.
  • 2Vansant G,Mertens A,Muls E.The effect of atorvastatin on postprandial lipaemia in overweight or obese women homozy gous for apoE3[J].Acta Cardiol,2001,56:149-154.
  • 3Nordoy A,Hansen JB,Brox J.Effects of atorvastatin and omega-3 fatty acids on LDL subfractions and postprandial hyperlipemia in patients with combined hyperlipemia[J].Nutr Metab Cardiovasc Disease,2001,11:7-16.
  • 4Sharret AR,Chambless LE,Heiss G,et al.Associatoin of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotic carotid artery atherosclerosis in middle-aged men and women. The atherosclerosis risk in communities(ARLC) study[J]. Arterioscler Thromb Vase Biol, 1995,15: 2122-2129.
  • 5Zliversmit DB.Atherogenesis:a postprandial phenomenon[J].Circulation,1979,60:473-483.
  • 6Kugiyma K,Doi H,Motoyama T,et al.Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries[J]. Circulation, 1998,37:832-837.
  • 7lli T,Raitakar,David S,Celermajer,et al.Flow-mediated dilatation[J].Br J Clin Pharmacol,2000,50:397-404.
  • 8Tadder S,Vivdis A,Ghiadoni L,et al.The role of endothelium in human hypertension[J]. Curr Opin Nep.hrol Hypertens,1998,7:203-209.
  • 9Khder Y,Briancon S,Petermann R,et al.Shear stress abnormalities contribute to endothelial dysfunction in hypertension but not in type Ⅱ diabetes[J]. J Hypertens, 1998, 16: 1619-1625.
  • 10Drexler H.Hypertension,heart failure,and endothelial function[J].Am J Cardiol,1998,82:205-225.

共引文献12

同被引文献40

  • 1刘方武,刘俊华,李会芹.他汀类药物非降脂作用的应用前景[J].中国误诊学杂志,2005,5(3):572-572. 被引量:5
  • 2史旭波,胡大一.他汀类药物的非降脂作用[J].中国民康医学,2006,18(9):334-335. 被引量:17
  • 3Calabro P, Yeh ET. Multitasking of the 3-hydroxy-3- methylglutaryl coenzyme a Atheroscler reductase inhibitor: beyond cardiovascular diseases. Curr Rep, 2004, 6:36-41.
  • 4Hoesel LM,Gao H,Ward PA. New insights into cellular mechanisms during sepsis[J].Immunologic Research,2006,(02):133-141.doi:10.1385/IR:34:2:133.
  • 5Fidan H,Sahin O,Yavuz Y. Caffeic acid phenethyl ester reduces mortality and sepsis-induced lung injury in rats[J].Critical Care Medicine,2007,(12):2822.doi:10.1097/01.CCM.0000295588.86982.7D.
  • 6Mc-Gown CC,Brookes ZLS. Beneficial effects of statins on the microcirculation during sepsis:the role of nitric oxide[J].British Journal of Anaesthesia,2007,(2):163-175.doi:10.1093/bja/ael358.
  • 7Waldow T,Witt W,Weber E. Nitric oxide donorinduced persistent inhibition of cell adhesion protein expression and NFkappaB activation in endothelial cells[J].Nitric Oxide:Biology and Chemistry,2006.103-113.
  • 8Yildiz A,Cakar MA,Baskurt M. The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease[J].Cardio-vasc Ultrasound,2007.51.doi:10.1186/1476-7120-5-51.
  • 9Fox A,Smythe J,Fisher N. Mobilization of endothelial progenitor cells into the circulation in burned patients[J].British Journal of Surgery,2008,(02):244-251.
  • 10Kusuyama T,Omura T,Nishiya D. The effects of HMG-CoA reductase inhibitor on vascular progenitor cells[J].Journal of Pharmaceutical Sciences,2006.344-349.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部